Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

NCT ID
NCT07494084
Registry status
Recruiting
Study type
Not specified in the registry data
Phase
Phase 4
Sponsor
Washington State University

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 48 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages
Not specified in the registry data
Sex
Not specified in the registry data
Healthy volunteers accepted
Yes

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: 1. Must be between 18-45 years old. 2. Has a BMI of 18-25 kg/m2 stable weight over the previous 6 weeks. 3. Is physically and psychologically healthy (incl. regular menstrual cycles in women, no clinical disorders and/or illnesses). Women will be studied during the follicular phase of their menstrual cycle. Menstrual cycle criteria (using PMID 10941950) 18 to 25 years - Cycle variation ≤9 days 26 to 41 years - Cycle variation ≤7 days 42 to 45 years - Cycle variation ≤9 days 4. No current medical or drug treatment (to include steroids or hormones of any type including contraceptives), as assessed by questionnaire. 5. Has a negative pregnancy test (women), no clinically significant abnormalities in blood and urine, and free of traces of drugs. 6. No history of clinically relevant psychiatric illness. 7. No previous history of drug or alcohol abuse. 8. Not a current smoker. 9. No history of brain injury or of learning disability. 10. No previous adverse reaction to sleep deprivation, jet lag, shift work or any of the drugs to be administered. 11. Not vision or hearing impairment unless corrected back to normal. 12. No endocrine disorder (no abnormal thyroid function tests; no abnormal morning blood cortisol; no primary gonadal disease as indicated by serum LH or FSH concentration \> 10 or \> 15 IU/L, respectively; and no hyperprolactinemia indicated by prolactin \> 25 μg/L). 13. No sleep or circadian disorder. 14. Has good habitual sleep with regular bedtimes (between 6 and 10 hours in duration). 15. Not extreme morning- nor extreme evening-type using Horne-Ostberg Morningness-Eveningness criteria. 16. No travel across time zones within one month of entering the study. 17. No shift work within three months of entering the study. 18. No anemia (hematocrit \<38% in men, \<34% in women). 19. No blood donation within the previous 8 weeks. 20. No concurrent participation in another research study.

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

  • Washington, United States: 1

Sample of listed locations

  • Sleep and Performance Research Center — Spokane, Washington, 99202, United States — Site recruitment status not specified in the registry data

Study details

Start date
July 16, 2026
Primary completion date
March 1, 2029
First posted
March 27, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07494084
Registry last updated
September 18, 2026
QualifiedStudies registry data refreshed
September 21, 2026

View NCT07494084 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Diabetes (Type II) studies | Clinical trial FAQ